Robert Shoemaker
Technik-/Wissenschafts-/F&E-Leiter bei ERASCA, INC.
Aktive Positionen von Robert Shoemaker
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ERASCA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 18.01.2022 | - |
| Corporate Officer/Principal | 01.07.2018 | 18.01.2022 |
Karriereverlauf von Robert Shoemaker
Ehemalige bekannte Positionen von Robert Shoemaker
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ILLUMINA, INC. | Corporate Officer/Principal | 01.01.2011 | 01.01.2012 |
| IGNYTA INC | Corporate Officer/Principal | 01.11.2013 | - |
Ignyta Operating, Inc.
 Ignyta Operating, Inc. Pharmaceuticals: MajorHealth Technology Ignyta Operating, Inc. develops molecular diagnostics for cancer and immunology. It is a biotechnology company developing personalized medicines for high unmet need cancer indications, based on cancer genome mining and sequencing. The firm's products include TrailblazeDx for RA, TrailblazeTx for RA, TrailblazeDx for SLE, TrailblazePx for SLE and TrailblazeTx for SLE. The company was founded in August 2011 by Jonathan E. Lim and Gary S. Firestein and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01.01.2012 | - |
Ausbildung von Robert Shoemaker
| University of California San Diego | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Corporate Officer/Principal | 4 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ILLUMINA, INC. | Health Technology |
| ERASCA, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Ignyta Operating, Inc.
Ignyta Operating, Inc. Pharmaceuticals: MajorHealth Technology Ignyta Operating, Inc. develops molecular diagnostics for cancer and immunology. It is a biotechnology company developing personalized medicines for high unmet need cancer indications, based on cancer genome mining and sequencing. The firm's products include TrailblazeDx for RA, TrailblazeTx for RA, TrailblazeDx for SLE, TrailblazePx for SLE and TrailblazeTx for SLE. The company was founded in August 2011 by Jonathan E. Lim and Gary S. Firestein and is headquartered in San Diego, CA. | Health Technology |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Ignyta, Inc. operates as a medicine biotechnology company. The firm engages in the discovering, acquiring, developing and commercializing targeted new drugs for cancer patients. The company was founded by Jonathan E. Lim on September 13, 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Robert Shoemaker
- Erfahrung
